Magen BioSciences Inc.

Magen BioSciences is using its co-founder's new research findings on the signaling pathways underlying melanin production to develop drugs for disfiguring dermatological pigmentation disorders.

790 Memorial Drive

Suite 200B

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip